Yes, genomic data can help predict histological outcomes, particularly in the context of disease progression and treatment response. For instance, identifying specific mutations or gene expression profiles associated with cancer can predict tumor behavior and guide personalized treatment strategies, which can be observed histologically through changes in tissue architecture.
